Vessel caliber--a potential MRI biomarker of tumour response in clinical trials.

Nature reviews. Clinical oncology

Volumn 11, Issue 10, 2014, Pages 566-584

  Emblem, Kyrre E ^a   Farrar, Christian T ^a   Gerstner, Elizabeth R ^a   Batchelor, Tracy T ^a   Borra, Ronald J H ^a   Rosen, Bruce R ^a   Sorensen, A Gregory ^a   Jain, Rakesh K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; TUMOR MARKER;

BLOOD VESSEL; CLINICAL TRIAL (TOPIC); HUMAN; METABOLISM; METHODOLOGY; NEOVASCULARIZATION (PATHOLOGY); NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; REVIEW; ULTRASTRUCTURE;

ANGIOGENESIS INDUCING AGENTS; ANGIOGENESIS INHIBITORS; BLOOD VESSELS; CLINICAL TRIALS AS TOPIC; HUMANS; MAGNETIC RESONANCE IMAGING; NEOVASCULARIZATION, PATHOLOGIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84909990047     PISSN: None     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2014.126     Document Type: Review

References (0)